Needham & Company LLC reissued their buy rating on shares of Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) in a research note published on Friday morning, Benzinga reports. They currently have a $50.00 price objective on the stock. RYTM has been the subject of a number of other reports. Wells Fargo & Company boosted their target […]
Needham & Company LLC reiterated their buy rating on shares of Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) in a research report report published on Friday morning, Benzinga reports. They currently have a $50.00 target price on the stock. A number of other equities research analysts have also recently issued reports on RYTM. Wells Fargo & […]
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) traded down 3.6% during trading on Thursday . The company traded as low as $44.44 and last traded at $44.79. 59,079 shares were traded during mid-day trading, a decline of 92% from the average session volume of 759,624 shares. The stock had previously closed at $46.46. Analysts […]
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report)’s stock price gapped down prior to trading on Monday . The stock had previously closed at $47.20, but opened at $45.74. Rhythm Pharmaceuticals shares last traded at $46.02, with a volume of 87,390 shares trading hands. Wall Street Analysts Forecast Growth A number of research firms have […]